Ancora Advisors’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Ancora Advisors’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-99	Closed	-$1K	–	2497
2021 Q3	$1K	Sell	99 -1	-1%	-$10	﹤0.01%	2150
2021 Q2	$1K	Buy	+100	New	+$1.01K	﹤0.01%	1912

Other funds holding MTACU

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ancora Advisors's MTACU Position: Q4 2021 in Review

Ancora Advisors sold out of MedTech Acquisition Corporation Unit (MTACU) in Q4 2021, closing a stake of 99 shares — an estimated $1K sold.

Ancora Advisors first reported a position in MTACU in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 11 funds tracked by Wall St. Rank hold MTACU as of Q4 2021.

Ancora Advisors reported no remaining MedTech Acquisition Corporation Unit position as of Q4 2021 after selling out during the quarter.
Ancora Advisors sold 99 MedTech Acquisition Corporation Unit shares in Q4 2021, an estimated $1K.
Ancora Advisors first reported a position in MedTech Acquisition Corporation Unit in Q2 2021 and held it in 2 quarters.
Ancora Advisors's MedTech Acquisition Corporation Unit position peaked at $1K in Q3 2021.
11 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q4 2021.

Based on Ancora Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.